Eyenovia Inc.

Eyenovia Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Eyenovia Inc. is not a good value stock. Eyenovia Inc. is a mediocre stock to choose.
Log in to see more information.
Eyenovia, Inc. is an emerging growth clinical stage biopharmaceutical company, which engages in the...
EYEN Fundamental Data by TradingView

News

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

PR Newswire Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization Formosa Pharmaceuticals Makes First Shipment...\n more…

Eyenovia announces Formosa granted Taiwan Export License
Eyenovia announces Formosa granted Taiwan Export License

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Globe Newswire Eyenovia is planning for a U.S. launch for Clobetasol in late September 2024NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with...\n more…

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer
Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Globe Newswire Current CFO, John Gandolfo, to remain with the Company through November as part of planned retirement transitionNEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a...\n more…

Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Update
Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Update

Ticker Report Eyenovia, Inc. (NASDAQ:EYEN - Get Free Report) was the recipient of a significant increase in short interest in August. As of August 15th, there was short interest totalling 3,030,000 shares, an...\n more…

Eyenovia, Inc. (NASDAQ:EYEN) CEO Acquires $28,500.00 in Stock
Eyenovia, Inc. (NASDAQ:EYEN) CEO Acquires $28,500.00 in Stock

Ticker Report Eyenovia, Inc. (NASDAQ:EYEN - Get Free Report) CEO Michael M. Rowe bought 50,000 shares of the company's stock in a transaction that occurred on Monday, August 26th. The shares were bought at an...\n more…